Author(s):
Rushiraj R. Jodave, Dinesh R. Bamane, Aviraj B Jambhale, Khelbude P., Hotkar N.
Email(s):
rushirajjodave@gmail.com
DOI:
10.52711/2231-3915.2024.00019 
Address:
Rushiraj R. Jodave, Dinesh R. Bamane, Aviraj B Jambhale, Khelbude P., Hotkar N.
Lokmangal College Of Pharmacy, Wadala, Solapur, Maharashtra, India -413222
*Corresponding Author
Published In:
Volume - 14,
Issue - 2,
Year - 2024
ABSTRACT:
Cancer encompasses a collection of diseases marked by the unrestrained growth and spread of abnormal cells. When this growth unchecked, it may lead to tumors, harm to bodily tissues, and the dissemination (metastasis) to various other areas of the body. There are numerous cancer types, such as breast cancer, lung cancer, prostate cancer, skin cancer, each different regions. Typically, cancer originates from genetic mutations that interfere with normal cellular regulation, prompting cells to multiply uncontrollably. These mutations may be inherited, triggered by environmental influences (including smoking, radiation, or exposure to cancer-causing agents), or they can occur spontaneously. Treatment alternatives vary based on the cancer type and stage, potentially involving surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapies. Detecting cancer early through screenings can significantly enhance the prospects for effective treatment. Synthetic drugs for cancer therapy aim to precisely focus on cancer cells, prevent tumor advancement, or enhance the body’s immune system in combating the disease. Herbal medicines, sourced from natural plants, have been utilized in traditional medicine for centuries and are increasingly recognized in contemporary healthcare due to their potential healing properties. These natural substances provide a broad array of pharmacological advantages, such as antioxidant, anti-inflammatory, antimicrobial, and anticancer effects. Their capacity to influence various biological pathways makes them essential in managing intricate conditions, including cancer, heart diseases, and neurodegenerative disorders.
Cite this article:
Rushiraj R. Jodave, Dinesh R. Bamane, Aviraj B Jambhale, Khelbude P., Hotkar N.. Herbal Drugs: Role in the Treatment of Cancer. International Journal of Technology. 2024; 14(2):132-8. doi: 10.52711/2231-3915.2024.00019
Cite(Electronic):
Rushiraj R. Jodave, Dinesh R. Bamane, Aviraj B Jambhale, Khelbude P., Hotkar N.. Herbal Drugs: Role in the Treatment of Cancer. International Journal of Technology. 2024; 14(2):132-8. doi: 10.52711/2231-3915.2024.00019 Available on: https://ijtonline.com/AbstractView.aspx?PID=2024-14-2-10
REFERENCES:
1. Hasanpoor Dehkordi A, Azari S. Quality of life and related factor in cancer patients. Behbood. 2006;10(2):110–119.
2. Tabari F, Zakeri Moghadam M, Bahrani N, Monjamed Z. Evaluation of the Quality of Life in newly Recognized Cancer Patients. HAYAT. 2007;13(2):5–12.
3. Mardani Hamule M, Shahraky Vahed A. The Assessment of Relationship between Mental Health and Quality of Life in Cancer Patients. Scientific Journal of Hamadan University of Medical Sciences. 2009;16(2):33–38.
4. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009; 59:225–249. doi: 10.3322/caac.20006.
5. MacMahon B. Cigarette smoking and cancer of the breast. In: Wald N, Baron J, editors. Smoking and hormone related disorders. Oxford: Oxford University Press; 1990. pp. 154–166.
6. Luo J, Solimini NL, Elledge SJ. (2009). Principles of cancer therapy: oncogene and nononcogene addiction. Cell, 136(5):823–37.
7. Sudhakar A. (2009). History of cancer, ancient and modern treatment methods. J Cancer Sci Ther, 1(2):1–4.
8. Van Dyke T, Jacks T. (2002). Cancer modeling in the modern era: progress and challenges. Cell, 108(2):135–44.
9. Upadhyay A. Cancer: An unknown territory; rethinking before going ahead. Genes Dis. 2020 Sep 18;8(5):655-661.
10. Lambert A.W., Pattabiraman D.R., Weinberg R.A. Emerging biological principles of metastasis. Cell. 2017;168(4):670–691.
11. Mroz E.A., Rocco J.W. The challenges of tumor genetic diversity. Cancer. 2017;123(6):917–927.
12. Hanselmann R.G., Welter C. Origin of cancer: an information, energy, and matter disease. Front Cell Dev Biol. 2016;4 doi: 10.3389/fcell.2016.00121.
13. Greaves M. Evolutionary determinants of cancer. Canc Discov. 2015;5(8):806–820. doi: 10.1158/2159-8290.CD-15-0439.
14. Palumbo M.O., Kavan P., Miller W.H. Jr. Systemic cancer therapy: achievements and challenges that lie ahead. Front Pharmacol. 2013;4 doi: 10.3389/fphar.2013.00057.
15. Turnbull A.K. Personalized medicine in cancer: where are we today? Future Oncol. 2015;11(20):2795–2798. doi: 10.2217/fon.15.204.
16. Wheeler H.E., Maitland M.L., Dolan M.E., Cox N.J., Ratain M.J. Cancer pharmacogenomics: strategies and challenges. Nat Rev Genet. 2013;14(1):23–34. doi: 10.1038/nrg3352.
17. Viral D, Shivanand P, Jivani N. Anticancer Evaluation of Adiantum venustum Don. J Young Pharm. 2011 Jan;3(1):48-54.
18. Manirakiza A, Irakoze L, Manirakiza S. Aloe and its Effects on Cancer: A Narrative Literature Review. East Afr Health Res J. 2021;5(1):1-16.
19. Gao Y, Kuok KI, Jin Y, Wang R. Biomedical applications of Aloe vera. Crit Rev Food Sci Nutr. 2018;1–13 Medline.
20. Aher V, Wahi A (2011) Biotechnical approach to evaluate immunomodulatory activity of ethanolic extract of Tinospora cordifolia stem (mango plant climber). Iran J Pharm Res 3:863–872.
21. Aher V, Wahi A (2011) Biotechnical approach to evaluate immunomodulatory activity of ethanolic extract of Tinospora cordifolia stem (mango plant climber). Iran J Pharm Res 3:863–872.
22. Kim J.S, Lee S.I, Park H.W, editors. Cytotoxic components from the dried rhizomes of Zingiber offici-naleRoscoe. Arch Pharm Res. 2008;31:415–8.
23. Ahmed R.S, Suke S.G, Seth V, Chakraborti A, Tripathi A.K, Banerjee B.D. Protective effects of dietary ginger (Zingiber officinales Rosc.) on lindane-induced oxidative stress in rats. Phytother Res. 2008;22:902–6.
24. Bidinotto L.T, Spinardi-Barbisan A.L, Rocha N.S, Salvadori D.M, Barbisan L.F. Effects of ginger (Zingiber officinale Roscoe) on DNA damage and development of urothelial tumors in a mouse bladder carcinogenesis model. Environ Mol Mutagen. 2006;47:624–30.
25. Aggarwal B.B. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other neutraceuticals. Annu Rev Nutr. 2010;30:173–199. Epub, Apr 26.
26. Aruna K, Sivaramakrishnan V.M. Plant products as protective agents against cancer. Indian J Exp Biol. 1990;28:1008–11.
27. Aruna K, Rukkumani R, Menon V.P. Role of Cuminum cyminum on ethanol and preheated sunflower oil induced lipid peroxidation. J Herbs Spices Med Plants. 2005;11:103–14.